Narayana Hrudayalaya Revenue Surges 75.8% in Q4 FY26 Driven by Acquisition

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Narayana Hrudayalaya Revenue Surges 75.8% in Q4 FY26 Driven by Acquisition
Overview

Narayana Hrudayalaya reported a strong Q4 FY26 with consolidated revenue soaring 75.8% year-on-year to ₹25,938 million. Full-year revenue increased 44.0% to ₹78,960 million. The acquisition of UK-based Practice Plus Group in November 2025 is a major contributor to this growth.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Narayana Hrudayalaya Reports Strong Q4 FY26 Financial Results

Narayana Hrudayalaya Ltd. announced significant financial gains for the fourth quarter and full year of FY26. Consolidated revenue for the fourth quarter reached ₹25,938 million, an impressive 75.8% increase compared to the same period last year. For the entire fiscal year 2026, consolidated revenue climbed 44.0% to ₹78,960 million.

Key Financials and Performance

The company also reported adjusted EBITDA for FY26 at ₹17,928 million, up 31.0% year-on-year. Adjusted Profit After Tax (PAT) for the full year was ₹9,374 million, an 18.7% increase from the previous year. Narayana Hrudayalaya's net debt stood at ₹22,397 million, with a net debt to equity ratio of 0.49, indicating a manageable debt load.

Impact of Acquisition and Strategy

These robust financial results highlight successful operational performance and the effective integration of recent acquisitions. The substantial revenue growth in Q4 is largely attributed to the acquisition of the UK-based Practice Plus Group in November 2025. This strategic move has expanded Narayana Hrudayalaya's international footprint, particularly in the UK market.

The company continues to focus on its integrated healthcare delivery model, known as 'Narayana One Health,' aiming to leverage its services across an enlarged network.

Considerations for Investors

It is important for investors to note that the reported UK operating revenue for FY26 reflects income from the acquisition date of November 6th, 2025. This means the full fiscal year's figures do not represent a complete 12-month operational period for the acquired UK business. This factor should be considered when assessing the company's growth trajectory.

Future Outlook

Narayana Hrudayalaya is expected to focus on further integrating its new operations and scaling its existing business model. The company's manageable debt profile suggests capacity for continued growth initiatives.

Upcoming Investor Briefing

Investors can expect further details and insights during the company's conference call scheduled for May 26, 2026, at 03:00 PM IST. This session will offer management's perspective on performance, future strategies, and the outlook for integrated operations.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.